Drug intelligence / Profile preview

aluminum hydroxide + magnesium oxide

Development stage: Unknown
Lead developer: Sanofi
Modality: Small Molecules
Administration: Oral

Overview

This combination medication contains aluminum hydroxide (algeldrate) and magnesium oxide, which work together as antacids to neutralize stomach acid. It is used to relieve heartburn, acid indigestion, and upset stomach. Aluminum hydroxide neutralizes stomach acid without increasing pH above 7, preventing excess acid secretion, while magnesium oxide provides quicker relief and counteracts the constipating effects of aluminum hydroxide with its mild laxative properties.

Other names: algeldrate + magnesium oxide

Beyond the preview

Go deeper on aluminum hydroxide + magnesium oxide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on aluminum hydroxide + magnesium oxide.

Explore the full profile